학술논문
Subanalyses of the Telaprevir Lead-in ARM in the Realize Study: Response at Week 4 is Not a Substitute for Prior Null Response Categorization
Document Type
Abstract
Author
Source
In Gastroenterology 2011 140(5) Supplement 1:S
Subject
Language
ISSN
0016-5085